| Autor: |
M. L. N. Willoughby, B. Lampkin |
| Rok vydání: |
1992 |
| Předmět: |
|
| Zdroj: |
Cancer in Children ISBN: 9783642847240 |
| DOI: |
10.1007/978-3-642-84722-6_10 |
| Popis: |
Although less frequent than acute lymphoblastic leukaemia (ALL) the incidence of acute myeloid leukaemia (AML) is still significant, constituting approximately 20% of childhood acute leukaemia cases in large series [1]. Compared with childhood ALL, the treatment of AML is less satisfactory because of (a) lower remission rate, (b) lower percentage of long-term survivors and (c) greater need for supportive measures to combat infection and haemorrhage during initial induction therapy. Bone marrow transplantation (BMT) during first remission may also have a more important role in AML than in ALL. Children and adolescents with all types of leukaemia should be treated at specialized centres since research is still needed before the biology and treatment of all types can be understood. Patients with AML in particular should be referred to specialized centres since the treatment is complicated, and results are superior at such centres. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
